RDGL — VIVOS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1449349 ·
Last close
$0.05
Market Cap
$25.95M
52W High
$0.12
52W Low
$0.05
ADV30
1,264,064
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 36,068 | -8,018 | -545,492 | -1,184,845 | 2,950,505 | 2,525,782 | 253,195 |
| Dec 2025 | 24,752 | -3,105 | -1,095,719 | -1,078,514 | 1,867,583 | 1,558,525 | 206,743 |
| Sep 2025 | 1,879 | -12,815 | -531,023 | -507,294 | 2,295,185 | 2,202,109 | 112,693 |
| Jun 2025 | 15,000 | -34,753 | -674,772 | -645,513 | 2,775,556 | 2,660,590 | 96,458 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,032,406
Investing CF
$-151,205
Financing CF
$1,547,478
CapEx
$-151,205
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-89,612,091
Inventory
$56,863
Receivables
$7,668
ST Investments
—
EBIT TTM
$-2,847,006
Pretax Income TTM
$-3,416,166
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$99,099
EBITDA
—
Free Cash Flow
$-1,544,673
Enterprise Value
$33,359,872
Total Cash
$2,336,022
Total Debt
$103,153
Shares Out
494,214,360
Trailing EPS
$-0.01
Book Value
$-0.01
ROE
-132.5%
ROA
-62.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 68,379 | -3,165,047 | -3,066,017 | 1,867,583 | 206,743 | — | -2,057,743 |
| Dec 2024 | 27,995 | -2,604,384 | -2,910,448 | 2,233,456 | 86,209 | — | -1,684,039 |
| Dec 2023 | 19,500 | -2,793,146 | -2,894,753 | 1,610,124 | 245,004 | — | -1,293,023 |
| Dec 2022 | 36,499 | -2,517,749 | -2,470,161 | 1,742,736 | 81,692 | — | -1,120,058 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PSTV | CERENOME, INC. | $26.42M | $3.84 | — |
| PETV | PetVivo Holdings, Inc. | $26.47M | $0.70 | — |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | $26.71M | $1.52 | — |
| FEMY | FEMASYS INC | $24.96M | $2.98 | — |
| GTHP | GUIDED THERAPEUTICS INC | $24.13M | $0.25 | — |
News headlines (Yahoo Finance, 1h cache)
Vivos Begins IsoPet Shipments and Secures India Manufacturing Authorization
2026-08-18 14:47 · Yahoo
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufactur
2026-08-18 12:30 · Yahoo
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
2026-08-14 12:45 · Yahoo
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction
2026-07-27 14:49 · Yahoo
Vivos Reports FDA IDE Approval and Expands Precision Radionuclide Therapy Programs
2026-07-27 14:44 · Yahoo
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™
2026-07-06 12:30 · Yahoo
Vivos Receives Washington Radioactive Materials License for IsoPet Manufacturing, Enabling Domestic Production Expansion (RDGL)
2026-06-11 14:51 · Yahoo
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
2026-06-05 12:30 · Yahoo
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
2026-06-22 12:30 · Yahoo
Vivos Therapeutics Secures New U.S. Patent Expanding Protection for Vivos CARE Technology
2026-08-05 14:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.